Fulgent Genetics Inc Cash Flow-to-Debt Ratio
Fulgent Genetics Inc cash flow-to-debt ratio. Fulgent Genetics Inc (FLGT) has a Cash Flow-to-Debt Ratio of -0.25x as of June 2026, meaning its operating cash flow of $-23.76 Million could theoretically repay 0% of its total liabilities ($93.24 Million) in one year. Check Fulgent Genetics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Fulgent Genetics Inc (2014–2025)
Cash flow-to-debt ratio of Fulgent Genetics Inc from 2014 to 2025. Historical debt coverage capacity for Fulgent Genetics Inc across 12 annual periods. Check FLGT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Fulgent Genetics Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
Fulgent Genetics Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Fulgent Genetics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Fulgent Genetics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.95x | $-101.64 Million | $106.81 Million | ▼ -510.3% |
| 2024 | 0.23x | $21.06 Million | $90.81 Million | ▼ -12.4% |
| 2023 | 0.26x | $27.00 Million | $102.04 Million | ▼ -87.9% |
| 2022 | 2.18x | $253.52 Million | $116.18 Million | ▼ -54.3% |
| 2021 | 4.77x | $538.58 Million | $112.84 Million | ▲ +344.9% |
| 2020 | 1.07x | $140.63 Million | $131.07 Million | ▲ +16.3% |
| 2019 | 0.92x | $5.52 Million | $5.98 Million | ▲ +475.2% |
| 2018 | -0.25x | $-675.00K | $2.75 Million | ▼ -154.0% |
| 2017 | 0.46x | $1.33 Million | $2.92 Million | ▼ -63.2% |
| 2016 | 1.24x | $4.41 Million | $3.56 Million | ▲ +187.6% |
| 2015 | -1.41x | $-969.00K | $686.00K | ▲ +86.0% |
| 2014 | -10.08x | $-4.40 Million | $436.00K | — |